Author

Xingyuan Liu

Chinese University of Hong KongORCID 0000-0003-4833-0765Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Research Focus:cell-cell communication· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Huating WangiD· 2 shared Yang LiiD· 2 shared Yulong QiaoiD· 2 shared Catherine C. L. WongiD· 1 shared Chuhan Li· 1 shared Chuhan LiiD· 1 shared Guanghou ShuiiD· 1 shared Hao Sun· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Huating WangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintSep 22, 2026

Multiomics Characterization Identifies S1P-secreting USSHigh Skeletal Muscle Stem Cells as Essential Drivers of Niche Remodeling and Muscle Regeneration

Xingyuan Liu, Yingkun Zhang, Yang Li…·Huating Wang

The paper identifies a senescent-like muscle stem cell subpopulation that drives muscle regeneration through secretory activity and cell communication.

DOI 10.64898/2026.09.18.752516

mousescRNA-seq

𝕏 PostBluesky

Cell BiologyNature CommunicationsPeer-reviewedJul 5, 2025

Multiomics mapping and characterization of cellular senescence in aging human skeletal muscle uncovers a novel senotherapeutic for sarcopenia

Yang Li, Chuhan Li, Qin Zhou…·Huating Wang

This study uses single-nucleus multiomics to characterize senescence in human skeletal muscle, identifies SASP factors, and proposes Maraviroc as a senotherapeutic for sarcopenia.

58 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky